We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+17.61%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$10.6B
AUM Growth
+$1.44B
Cap. Flow
+$92.7M
Cap. Flow %
0.88%
Top 10 Hldgs %
22.72%
Holding
2,357
New
64
Increased
127
Reduced
1,296
Closed
88

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$395M
2
TSLA icon
Tesla
TSLA
+$94.3M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$23M
4
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
+$4.29M
5
PRG icon
PROG Holdings
PRG
+$3.34M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$23.3M
2
MSFT icon
Microsoft
MSFT
+$17.8M
3
AMZN icon
Amazon
AMZN
+$13.9M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$10.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$8.35M

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Healthcare 12.78%
3 Financials 12.6%
4 Consumer Discretionary 11.75%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFC
1801
Ellington Financial
EFC
$1.76B
$282K ﹤0.01%
18,985
– –
COLL icon
1802
Collegium Pharmaceutical
COLL
$914M
$281K ﹤0.01%
14,032
– –
VVX icon
1803
V2X
VVX
$2.51B
$281K ﹤0.01%
5,647
– –
PDFS icon
1804
PDF Solutions
PDFS
$2.15B
$280K ﹤0.01%
12,971
– –
NX icon
1805
Quanex
NX
$978M
$279K ﹤0.01%
12,585
– –
NIC icon
1806
Nicolet Bankshares
NIC
$3.75B
$279K ﹤0.01%
4,200
– –
ICL icon
1807
ICL Group
ICL
$6.94B
$278K ﹤0.01%
54,463
– –
AXGN icon
1808
Axogen
AXGN
$2.61B
$277K ﹤0.01%
15,476
– –
ICPT
1809
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$277K ﹤0.01%
11,215
– –
TVRD
1810
Tvardi Therapeutics
TVRD
$21.9M
$276K ﹤0.01%
506
– –
FRG
1811
DELISTED
Franchise Group, Inc.
FRG
$275K ﹤0.01%
9,045
– –
CPS icon
1812
Cooper-Standard Automotive
CPS
$484M
$275K ﹤0.01%
7,930
– –
PASG icon
1813
Passage Bio
PASG
$14.8M
$274K ﹤0.01%
537
+196
+57% +$78.5K
BANC icon
1814
Banc of California
BANC
$3.14B
$274K ﹤0.01%
18,620
– –
ANGO icon
1815
AngioDynamics
ANGO
$649M
$274K ﹤0.01%
17,852
– –
DFIN icon
1816
Donnelley Financial Solutions
DFIN
$1.17B
$273K ﹤0.01%
16,100
– –
STRO icon
1817
Sutro Biopharma
STRO
$356M
$273K ﹤0.01%
1,258
– –
AGX icon
1818
Argan
AGX
$7.99B
$273K ﹤0.01%
6,140
– –
PTGX icon
1819
Protagonist Therapeutics
PTGX
$9.91B
$273K ﹤0.01%
13,524
– –
CLBK icon
1820
Columbia Financial
CLBK
$1.22B
$272K ﹤0.01%
17,478
-6,959
-28% -$96.3K
RMR icon
1821
The RMR Group
RMR
$342M
$271K ﹤0.01%
7,008
– –
TGI
1822
DELISTED
Triumph Group
TGI
$271K ﹤0.01%
21,541
-859
-4% -$8.91K
MITK icon
1823
Mitek Systems
MITK
$839M
$269K ﹤0.01%
15,147
– –
KREF
1824
KKR Real Estate Finance Trust
KREF
$496M
$269K ﹤0.01%
15,022
– –
AHRT
1825
AH Realty Trust
AHRT
$509M
$269K ﹤0.01%
23,985
– –
71 72
73
74 75

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

MetLife Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, MetLife Investment Management held 2,357 positions worth $10.6B, up 16% from $9.13B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q4 2020 filing shows 64 new, 127 increased, 1,296 reduced and 88 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M. The largest sale was Apple, an estimated $23.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2020 buy was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $23M increase.
  • MetLife Investment Management's biggest Q4 2020 reduction was Apple, cutting an estimated $23.3M.
  • MetLife Investment Management fully exited Dunkin' Brands Group, Inc. in Q4 2020, selling an estimated $3.86M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $10.6B portfolio in Q4 2020.
  • MetLife Investment Management opened 64 new positions and closed 88 in Q4 2020.
  • MetLife Investment Management's portfolio value rose 16% quarter-over-quarter to $10.6B.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.